Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis
Background:The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and their utility for the rapid immunodiagnosis of pulmonary TB is unclear.Methods:Antigen-specific interferon γ (IFNγ) responses to t...
Uloženo v:
| Vydáno v: | Thorax Ročník 64; číslo 10; s. 847 - 853 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
BMJ Publishing Group Ltd and British Thoracic Society
01.10.2009
BMJ Publishing Group BMJ Publishing Group LTD |
| Témata: | |
| ISSN: | 0040-6376, 1468-3296, 1468-3296 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Background:The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and their utility for the rapid immunodiagnosis of pulmonary TB is unclear.Methods:Antigen-specific interferon γ (IFNγ) responses to the RD-1 antigens ESAT-6 and CFP-10 (T-SPOT.TB and QuantiFERON-TB-Gold-In-Tube), heparin-binding haemagglutinin and purified protein derivative were evaluated, using alveolar lavage cells, in 91 consecutively recruited South African patients suspected of having TB.Results:Of 85 evaluable patients (29% HIV+), 24, 11, 48 and 2 had definite TB, probable TB, non-TB and an uncertain diagnosis, respectively. Between 34% (T-SPOT.TB) and 41% (QuantiFERON-TB-Gold-In-Tube) of all test results were inconclusive. Failure of the positive control was significantly higher with the QuantiFERON-TB-Gold-In-Tube than with T-SPOT.TB (85% vs 46% of inconclusive results; p = 0.001). Using staphylococcal enterotoxin B, compared with phytohaemagglutinin, substantially reduced failure of the positive control (25% to 3%; p = 0.02). In evaluable samples, when the definite and non-TB groups were used for outcome analysis, the percentage sensitivity, specificity, positive predictive value and negative predictive value for T-SPOT.TB (⩾20 spots/million alveolar mononuclear cells) and QuantiFERON-TB-Gold-In-Tube (0.35 IU/ml) were 89, 94, 89 and 94% (n = 55) and 55, 86, 77 and 69% (n = 46), respectively. Rapid diagnosis of TB was achieved more frequently with T-SPOT.TB than with smear microscopy (14/24 (58%) vs. 7/24 (29%) of definite TB cases; p = 0.02). Heparin-binding haemagluttinin and purified protein derivative alveolar lymphocyte IFNγ responses had poor performance outcomes.Conclusion:Provided evaluable results are obtained, the RD-1, but not the heparin-binding haemagglutinin or purified protein derivative, alveolar lymphocyte IFNγ ELISPOT response is a useful rapid immunodiagnostic test for TB. However, test utility in high-burden settings may be limited by the high proportion of inconclusive results. |
|---|---|
| AbstractList | The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and their utility for the rapid immunodiagnosis of pulmonary TB is unclear.
Antigen-specific interferon gamma (IFNgamma) responses to the RD-1 antigens ESAT-6 and CFP-10 (T-SPOT.TB and QuantiFERON-TB-Gold-In-Tube), heparin-binding haemagglutinin and purified protein derivative were evaluated, using alveolar lavage cells, in 91 consecutively recruited South African patients suspected of having TB.
Of 85 evaluable patients (29% HIV+), 24, 11, 48 and 2 had definite TB, probable TB, non-TB and an uncertain diagnosis, respectively. Between 34% (T-SPOT.TB) and 41% (QuantiFERON-TB-Gold-In-Tube) of all test results were inconclusive. Failure of the positive control was significantly higher with the QuantiFERON-TB-Gold-In-Tube than with T-SPOT.TB (85% vs 46% of inconclusive results; p = 0.001). Using staphylococcal enterotoxin B, compared with phytohaemagglutinin, substantially reduced failure of the positive control (25% to 3%; p = 0.02). In evaluable samples, when the definite and non-TB groups were used for outcome analysis, the percentage sensitivity, specificity, positive predictive value and negative predictive value for T-SPOT.TB (> or = 20 spots/million alveolar mononuclear cells) and QuantiFERON-TB-Gold-In-Tube (0.35 IU/ml) were 89, 94, 89 and 94% (n = 55) and 55, 86, 77 and 69% (n = 46), respectively. Rapid diagnosis of TB was achieved more frequently with T-SPOT.TB than with smear microscopy (14/24 (58%) vs. 7/24 (29%) of definite TB cases; p = 0.02). Heparin-binding haemagluttinin and purified protein derivative alveolar lymphocyte IFNgamma responses had poor performance outcomes.
Provided evaluable results are obtained, the RD-1, but not the heparin-binding haemagglutinin or purified protein derivative, alveolar lymphocyte IFNgamma ELISPOT response is a useful rapid immunodiagnostic test for TB. However, test utility in high-burden settings may be limited by the high proportion of inconclusive results. Background: The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and their utility for the rapid immunodiagnosis of pulmonary TB is unclear. Methods: Antigen-specific interferon [GAMMA] (IFN[GAMMA]) responses to the RD-1 antigens ESAT-6 and CFP-10 (T-SPOT.TB and QuantiFERON-TB-Gold-In-Tube), heparin-binding haemagglutinin and purified protein derivative were evaluated, using alveolar lavage cells, in 91 consecutively recruited South African patients suspected of having TB. Results: Of 85 evaluable patients (29% HIV+), 24, 11, 48 and 2 had definite TB, probable TB, non-TB and an uncertain diagnosis, respectively. Between 34% (T-SPOT.TB) and 41% (QuantiFERON-TB-Gold-In-Tube) of all test results were inconclusive. Failure of the positive control was significantly higher with the QuantiFERON-TB-Gold-In-Tube than with T-SPOT.TB (85% vs 46% of inconclusive results; pâ[euro]S=â[euro]S0.001). Using staphylococcal enterotoxin B, compared with phytohaemagglutinin, substantially reduced failure of the positive control (25% to 3%; pâ[euro]S=â[euro]S0.02). In evaluable samples, when the definite and non-TB groups were used for outcome analysis, the percentage sensitivity, specificity, positive predictive value and negative predictive value for T-SPOT.TB (⩾20 spots/million alveolar mononuclear cells) and QuantiFERON-TB-Gold-In-Tube (0.35 IU/ml) were 89, 94, 89 and 94% (nâ[euro]S=â[euro]S55) and 55, 86, 77 and 69% (nâ[euro]S=â[euro]S46), respectively. Rapid diagnosis of TB was achieved more frequently with T-SPOT.TB than with smear microscopy (14/24 (58%) vs. 7/24 (29%) of definite TB cases; pâ[euro]S=â[euro]S0.02). Heparin-binding haemagluttinin and purified protein derivative alveolar lymphocyte IFN[GAMMA] responses had poor performance outcomes. Conclusion: Provided evaluable results are obtained, the RD-1, but not the heparin-binding haemagglutinin or purified protein derivative, alveolar lymphocyte IFN[GAMMA] ELISPOT response is a useful rapid immunodiagnostic test for TB. However, test utility in high-burden settings may be limited by the high proportion of inconclusive results. Background:The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and their utility for the rapid immunodiagnosis of pulmonary TB is unclear.Methods:Antigen-specific interferon γ (IFNγ) responses to the RD-1 antigens ESAT-6 and CFP-10 (T-SPOT.TB and QuantiFERON-TB-Gold-In-Tube), heparin-binding haemagglutinin and purified protein derivative were evaluated, using alveolar lavage cells, in 91 consecutively recruited South African patients suspected of having TB.Results:Of 85 evaluable patients (29% HIV+), 24, 11, 48 and 2 had definite TB, probable TB, non-TB and an uncertain diagnosis, respectively. Between 34% (T-SPOT.TB) and 41% (QuantiFERON-TB-Gold-In-Tube) of all test results were inconclusive. Failure of the positive control was significantly higher with the QuantiFERON-TB-Gold-In-Tube than with T-SPOT.TB (85% vs 46% of inconclusive results; p = 0.001). Using staphylococcal enterotoxin B, compared with phytohaemagglutinin, substantially reduced failure of the positive control (25% to 3%; p = 0.02). In evaluable samples, when the definite and non-TB groups were used for outcome analysis, the percentage sensitivity, specificity, positive predictive value and negative predictive value for T-SPOT.TB (⩾20 spots/million alveolar mononuclear cells) and QuantiFERON-TB-Gold-In-Tube (0.35 IU/ml) were 89, 94, 89 and 94% (n = 55) and 55, 86, 77 and 69% (n = 46), respectively. Rapid diagnosis of TB was achieved more frequently with T-SPOT.TB than with smear microscopy (14/24 (58%) vs. 7/24 (29%) of definite TB cases; p = 0.02). Heparin-binding haemagluttinin and purified protein derivative alveolar lymphocyte IFNγ responses had poor performance outcomes.Conclusion:Provided evaluable results are obtained, the RD-1, but not the heparin-binding haemagglutinin or purified protein derivative, alveolar lymphocyte IFNγ ELISPOT response is a useful rapid immunodiagnostic test for TB. However, test utility in high-burden settings may be limited by the high proportion of inconclusive results. The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and their utility for the rapid immunodiagnosis of pulmonary TB is unclear.BACKGROUNDThe diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and their utility for the rapid immunodiagnosis of pulmonary TB is unclear.Antigen-specific interferon gamma (IFNgamma) responses to the RD-1 antigens ESAT-6 and CFP-10 (T-SPOT.TB and QuantiFERON-TB-Gold-In-Tube), heparin-binding haemagglutinin and purified protein derivative were evaluated, using alveolar lavage cells, in 91 consecutively recruited South African patients suspected of having TB.METHODSAntigen-specific interferon gamma (IFNgamma) responses to the RD-1 antigens ESAT-6 and CFP-10 (T-SPOT.TB and QuantiFERON-TB-Gold-In-Tube), heparin-binding haemagglutinin and purified protein derivative were evaluated, using alveolar lavage cells, in 91 consecutively recruited South African patients suspected of having TB.Of 85 evaluable patients (29% HIV+), 24, 11, 48 and 2 had definite TB, probable TB, non-TB and an uncertain diagnosis, respectively. Between 34% (T-SPOT.TB) and 41% (QuantiFERON-TB-Gold-In-Tube) of all test results were inconclusive. Failure of the positive control was significantly higher with the QuantiFERON-TB-Gold-In-Tube than with T-SPOT.TB (85% vs 46% of inconclusive results; p = 0.001). Using staphylococcal enterotoxin B, compared with phytohaemagglutinin, substantially reduced failure of the positive control (25% to 3%; p = 0.02). In evaluable samples, when the definite and non-TB groups were used for outcome analysis, the percentage sensitivity, specificity, positive predictive value and negative predictive value for T-SPOT.TB (> or = 20 spots/million alveolar mononuclear cells) and QuantiFERON-TB-Gold-In-Tube (0.35 IU/ml) were 89, 94, 89 and 94% (n = 55) and 55, 86, 77 and 69% (n = 46), respectively. Rapid diagnosis of TB was achieved more frequently with T-SPOT.TB than with smear microscopy (14/24 (58%) vs. 7/24 (29%) of definite TB cases; p = 0.02). Heparin-binding haemagluttinin and purified protein derivative alveolar lymphocyte IFNgamma responses had poor performance outcomes.RESULTSOf 85 evaluable patients (29% HIV+), 24, 11, 48 and 2 had definite TB, probable TB, non-TB and an uncertain diagnosis, respectively. Between 34% (T-SPOT.TB) and 41% (QuantiFERON-TB-Gold-In-Tube) of all test results were inconclusive. Failure of the positive control was significantly higher with the QuantiFERON-TB-Gold-In-Tube than with T-SPOT.TB (85% vs 46% of inconclusive results; p = 0.001). Using staphylococcal enterotoxin B, compared with phytohaemagglutinin, substantially reduced failure of the positive control (25% to 3%; p = 0.02). In evaluable samples, when the definite and non-TB groups were used for outcome analysis, the percentage sensitivity, specificity, positive predictive value and negative predictive value for T-SPOT.TB (> or = 20 spots/million alveolar mononuclear cells) and QuantiFERON-TB-Gold-In-Tube (0.35 IU/ml) were 89, 94, 89 and 94% (n = 55) and 55, 86, 77 and 69% (n = 46), respectively. Rapid diagnosis of TB was achieved more frequently with T-SPOT.TB than with smear microscopy (14/24 (58%) vs. 7/24 (29%) of definite TB cases; p = 0.02). Heparin-binding haemagluttinin and purified protein derivative alveolar lymphocyte IFNgamma responses had poor performance outcomes.Provided evaluable results are obtained, the RD-1, but not the heparin-binding haemagglutinin or purified protein derivative, alveolar lymphocyte IFNgamma ELISPOT response is a useful rapid immunodiagnostic test for TB. However, test utility in high-burden settings may be limited by the high proportion of inconclusive results.CONCLUSIONProvided evaluable results are obtained, the RD-1, but not the heparin-binding haemagglutinin or purified protein derivative, alveolar lymphocyte IFNgamma ELISPOT response is a useful rapid immunodiagnostic test for TB. However, test utility in high-burden settings may be limited by the high proportion of inconclusive results. |
| Author | van Zyl-Smit, R N Maredza, A Whitelaw, A Semple, P Bateman, E D Meldau, R Meldau, S Dheda, K Zumla, A Wainwright, H Rosu, V Sechi, L A Symons, G Dawson, R Badri, M Khalfey, H Govender, N |
| Author_xml | – sequence: 1 givenname: K surname: Dheda fullname: Dheda, K email: keertan.dheda@uct.ac.za organization: Centre for Infectious Diseases and International Health, University College Medical School, London, UK – sequence: 2 givenname: R N surname: van Zyl-Smit fullname: van Zyl-Smit, R N email: keertan.dheda@uct.ac.za organization: Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, South Africa – sequence: 3 givenname: R surname: Meldau fullname: Meldau, R email: keertan.dheda@uct.ac.za organization: Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, South Africa – sequence: 4 givenname: S surname: Meldau fullname: Meldau, S email: keertan.dheda@uct.ac.za organization: Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, South Africa – sequence: 5 givenname: G surname: Symons fullname: Symons, G email: keertan.dheda@uct.ac.za organization: Department of Medicine, University of Cape Town, South Africa – sequence: 6 givenname: H surname: Khalfey fullname: Khalfey, H email: keertan.dheda@uct.ac.za organization: Department of Medicine, University of Cape Town, South Africa – sequence: 7 givenname: N surname: Govender fullname: Govender, N email: keertan.dheda@uct.ac.za organization: Department of Medicine, University of Cape Town, South Africa – sequence: 8 givenname: V surname: Rosu fullname: Rosu, V email: keertan.dheda@uct.ac.za organization: Dipartimento di Scienze Biomediche, University of Sardinia, Sassari, Italy – sequence: 9 givenname: L A surname: Sechi fullname: Sechi, L A email: keertan.dheda@uct.ac.za organization: Dipartimento di Scienze Biomediche, University of Sardinia, Sassari, Italy – sequence: 10 givenname: A surname: Maredza fullname: Maredza, A email: keertan.dheda@uct.ac.za organization: Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, South Africa – sequence: 11 givenname: P surname: Semple fullname: Semple, P email: keertan.dheda@uct.ac.za organization: Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, South Africa – sequence: 12 givenname: A surname: Whitelaw fullname: Whitelaw, A email: keertan.dheda@uct.ac.za organization: Division of Medical Microbiology, University of Cape Town, South Africa – sequence: 13 givenname: H surname: Wainwright fullname: Wainwright, H email: keertan.dheda@uct.ac.za organization: Department of Anatomical Pathology, University of Cape Town, South Africa – sequence: 14 givenname: M surname: Badri fullname: Badri, M email: keertan.dheda@uct.ac.za organization: Department of Medicine, University of Cape Town, South Africa – sequence: 15 givenname: R surname: Dawson fullname: Dawson, R email: keertan.dheda@uct.ac.za organization: Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, South Africa – sequence: 16 givenname: E D surname: Bateman fullname: Bateman, E D email: keertan.dheda@uct.ac.za organization: Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, South Africa – sequence: 17 givenname: A surname: Zumla fullname: Zumla, A email: keertan.dheda@uct.ac.za organization: Centre for Infectious Diseases and International Health, University College Medical School, London, UK |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21959188$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19592392$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUtv1DAUhS1URKeFNTtkCdEFUlo_YidZohHvCjRoYGs5zk3rIWMH20Htv8chQ5G6gJVf37n3XJ8TdOS8A4SeUnJOKZcX6frmnBHS5JPklXyAVrSUdcFZI4_QipCSFPP9MTqJcUcIqSmtHqFj2oiG8Yat0HYzaZds0sn-BDxM7gpvsYFhwAHi6F2EiLXtcLoGHPSYd53VV85HG7Hv8TgNe-90uMVpaiGYaZhfHqOHvR4iPDmsp-jrm9fb9bvi8vPb9-tXl0VbyioVAojoO90K09Ku5T3VALw0DTBNu1qWRvbCMMGkka1oQFaC1L0UPXBGqgY4P0VnS90x-B8TxKT2Ns7mtQM_RSUrWTFekgw-vwfu_BRc9qZoVdOaybqimXp2oKZ2D50ag93n0dSf38rAiwOgo9FDH7QzNt5xbAZpXWfuYuFM8DEG6P-WImrOTeXc1JybWnLLCnFPYX5n4l0K2g7_0BWLzsYEN3dtdPieh-eVUJ--rRXfko9k82GjvmT-5cK3-91_Tf0CylK4bw |
| CODEN | THORA7 |
| CitedBy_id | crossref_primary_10_1016_j_ijmyco_2015_10_004 crossref_primary_10_1097_QAI_0b013e31820b07ab crossref_primary_10_1164_rccm_201006_0963PP crossref_primary_10_1164_rccm_201912_2425ED crossref_primary_10_1183_09031936_00115110 crossref_primary_10_1164_ajrccm_181_3_289a crossref_primary_10_1007_s15010_022_01789_9 crossref_primary_10_1016_j_tube_2020_101942 crossref_primary_10_1371_journal_pone_0039838 crossref_primary_10_1111_j_1440_1843_2010_01725_x crossref_primary_10_1586_17476348_2014_852471 crossref_primary_10_5812_jjm_14030 crossref_primary_10_1111_j_1365_2796_2011_02378_x crossref_primary_10_1164_rccm_201001_0140UP crossref_primary_10_1016_j_ijid_2017_08_008 crossref_primary_10_1183_13993003_02189_2017 crossref_primary_10_1080_14737159_2020_1858805 crossref_primary_10_1093_infdis_jir410 crossref_primary_10_1164_rccm_201001_0083OC crossref_primary_10_1183_09031936_00214611 crossref_primary_10_1164_rccm_201008_1246CI crossref_primary_10_1164_rccm_200912_1931OC crossref_primary_10_1111_tmi_12099 crossref_primary_10_1164_ajrccm_181_3_289 crossref_primary_10_1378_chest_09_2350 crossref_primary_10_5812_pedinfect_22368 crossref_primary_10_1111_j_1440_1843_2009_01692_x crossref_primary_10_1016_j_jinf_2011_04_001 crossref_primary_10_1111_j_1440_1843_2010_01739_x crossref_primary_10_1093_ofid_ofae496 crossref_primary_10_1097_MD_0000000000003183 crossref_primary_10_1183_09031936_00114810 crossref_primary_10_1111_j_1440_1843_2011_01941_x crossref_primary_10_1183_09059180_00000511 crossref_primary_10_1093_infdis_jir450 crossref_primary_10_1016_j_tube_2015_10_006 crossref_primary_10_1093_infdis_jis557 crossref_primary_10_1371_journal_pone_0037436 crossref_primary_10_1016_j_diagmicrobio_2011_05_013 crossref_primary_10_1155_2013_601737 crossref_primary_10_7326_ACPJC_2018_169_8_046 crossref_primary_10_1371_journal_pone_0032482 |
| ContentType | Journal Article |
| Copyright | BMJ Publishing Group Ltd and British Thoracic Society. All rights reserved. 2009 INIST-CNRS Copyright: 2009 BMJ Publishing Group Ltd and British Thoracic Society. All rights reserved. |
| Copyright_xml | – notice: BMJ Publishing Group Ltd and British Thoracic Society. All rights reserved. – notice: 2009 INIST-CNRS – notice: Copyright: 2009 BMJ Publishing Group Ltd and British Thoracic Society. All rights reserved. |
| DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR BTHHO CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1136/thx.2009.116376 |
| DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central BMJ Journals ProQuest One ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) BMJ Journals Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE ProQuest One Academic Middle East (New) MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1468-3296 |
| EndPage | 853 |
| ExternalDocumentID | 4027209551 19592392 21959188 10_1136_thx_2009_116376 ark_67375_NVC_3T0K0QJQ_R thoraxjnl |
| Genre | Evaluation Studies Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | South Africa Cape Town South Africa |
| GeographicLocations_xml | – name: South Africa – name: Cape Town South Africa |
| GroupedDBID | --- .55 .GJ .VT 08G 0R~ 123 18M 29Q 2WC 354 39C 3O- 4.4 40O 53G 5RE 5VS 6PF 7X7 7~S 88E 8F7 8FI 8FJ 8R4 8R5 AAHLL AAKAS AAOJX AAWJN AAWTL AAYEP ABAAH ABJNI ABKDF ABMQD ABOCM ABTFR ABUWG ABVAJ ACGFO ACGFS ACGTL ACHTP ACMFJ ACOAB ACOFX ACQSR ACTZY ADBBV ADCEG ADZCM AENEX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN BAWUL BENPR BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C45 CAG CCPQU COF CS3 CXRWF DIK DU5 E3Z EBS EJD F5P FEDTE FYUFA GX1 H13 HAJ HMCUK HVGLF HYE HZ~ IAO IEA IH2 IHR IOF ITC J5H KQ8 L7B M1P N4W N9A NTWIH NXWIF O9- OK1 OVD P2P PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 TEORI TR2 UAW UKHRP UYXKK V24 VM9 VVN W8F WH7 X7M YFH YOC YQY ZCG ZGI 3V. BSCLL RHF AAYXX ACQHZ AERUA AFFHD CITATION PHGZM PJZUB PPXIY ADGHP IQODW CGR CUY CVF ECM EIF NPM 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 |
| ID | FETCH-LOGICAL-b467t-5e05fdab5cb1db3f1aee34c9e2a1d864c6f5c2526c6b59e67508f65fe32079e33 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 56 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000270269700006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0040-6376 1468-3296 |
| IngestDate | Sun Nov 09 13:24:44 EST 2025 Tue Oct 07 06:48:40 EDT 2025 Mon Jul 21 06:04:23 EDT 2025 Mon Jul 21 09:14:48 EDT 2025 Tue Nov 18 22:40:33 EST 2025 Sat Nov 29 03:47:22 EST 2025 Wed Oct 30 09:41:01 EDT 2024 Thu Apr 24 23:05:36 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | Lung disease Respiratory disease Lung Pulmonary tuberculosis Cellular immunity Mycobacterial infection Infection Bacteriosis Anesthesia Circulatory system Diagnosis Cardiology Quantitative analysis |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b467t-5e05fdab5cb1db3f1aee34c9e2a1d864c6f5c2526c6b59e67508f65fe32079e33 |
| Notes | istex:F179394F03BEE78B15C40DFE7F98E18B3321BB50 href:thoraxjnl-64-847.pdf local:thoraxjnl;64/10/847 PMID:19592392 ark:/67375/NVC-3T0K0QJQ-R ArticleID:tx116376 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
| OpenAccessLink | https://thorax.bmj.com/content/thoraxjnl/64/10/847.full.pdf |
| PMID | 19592392 |
| PQID | 1781826871 |
| PQPubID | 2041050 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_67672340 proquest_journals_1781826871 pubmed_primary_19592392 pascalfrancis_primary_21959188 crossref_primary_10_1136_thx_2009_116376 crossref_citationtrail_10_1136_thx_2009_116376 istex_primary_ark_67375_NVC_3T0K0QJQ_R bmj_primary_10_1136_thx_2009_116376 |
| PublicationCentury | 2000 |
| PublicationDate | 2009-10-01 |
| PublicationDateYYYYMMDD | 2009-10-01 |
| PublicationDate_xml | – month: 10 year: 2009 text: 2009-10-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Thorax |
| PublicationTitleAlternate | Thorax |
| PublicationYear | 2009 |
| Publisher | BMJ Publishing Group Ltd and British Thoracic Society BMJ Publishing Group BMJ Publishing Group LTD |
| Publisher_xml | – name: BMJ Publishing Group Ltd and British Thoracic Society – name: BMJ Publishing Group – name: BMJ Publishing Group LTD |
| References | Hougardy, Schepers, Place 2007; 2 Bossuyt, Reitsma, Bruns 2003; 49 Pai, Zwerling, Menzies 2008; 149 Dheda, Chang, Breen 2005; 172 Delogu, Bua, Pusceddu 2004; 239 Delogu, Sanguinetti, Posteraro 2006; 74 Zanetti, Bua, Delogu 2005; 12 Silver, Zukowski, Kotake 2003; 29 Ling, Flores, Riley 2008; 3 Pai, Dheda, Cunningham 2007; 7 Ribeiro-Rodrigues, Resende, Johnson 2002; 9 Barry, Lipman, Bannister 2003; 187 Gerosa, Nisii, Righetti 1999; 92 Temmerman, Pethe, Parra 2004; 10 Dheda, Chang, Breen 2005; 19 Breen, Barry, Smith 2008; 63 Robinson, Ying, Taylor 1994; 149 Guyot-Revol, Innes, Hackforth 2006; 173 Jafari, Ernst, Strassburg 2008; 31 Dheda, Udwadia, Huggett 2005; 11 Sable, Goyal, Verma 2007; 29 Condos, Rom, Liu 1998; 157 Locht, Hougardy, Rouanet 2006; 86 Hougardy, Place, Hildebrand 2007; 176 Wilkinson, Wilkinson, Pathan 2005; 40 Ortbals, Marr 1978; 117 Mazurek, Weis, Moonan 2007; 45 Nemeth, Winkler, Zwick 2009; 265 Jafari, Ernst, Kalsdorf 2006; 174 20805186 - Thorax. 2010 Sep;65(9):842; author reply 842-3 |
| References_xml | – volume: 149 start-page: 989 year: 1994 article-title: Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis. publication-title: Am J Respir Crit Care Med – volume: 45 start-page: 837 year: 2007 article-title: Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. publication-title: Clin Infect Dis – volume: 29 start-page: 117 year: 2003 article-title: Recruitment of antigen-specific Th1-like responses to the human lung following bronchoscopic segmental challenge with purified protein derivative of mycobacterium tuberculosis. publication-title: Am J Respir Cell Mol Biol – volume: 172 start-page: 501 year: 2005 article-title: In vivo and in vitro studies of a novel cytokine, interleukin-4delta2, in pulmonary tuberculosis. publication-title: Am J Resp Crit Care Med – volume: 63 start-page: 67 year: 2008 article-title: Clinical application of a rapid lung-orientated immunoassay in individuals with possible tuberculosis. publication-title: Thorax – volume: 92 start-page: 224 year: 1999 article-title: CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. publication-title: Clin Immunol – volume: 117 start-page: 39 year: 1978 article-title: A comparative study of tuberculous and other mycobacterial infections and their associations with malignancy. publication-title: Am Rev Respir Dis – volume: 174 start-page: 1048 year: 2006 article-title: Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. publication-title: Am J Respir Crit Care Med – volume: 74 start-page: 3006 year: 2006 article-title: The hbha gene of Mycobacterium tuberculosis is specifically upregulated in the lungs but not in the spleens of aerogenically infected mice. publication-title: Infect Immun – volume: 49 start-page: 1 year: 2003 article-title: Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for reporting of diagnostic accuracy. publication-title: Clin Chem – volume: 173 start-page: 803 year: 2006 article-title: Regulatory T cells are expanded in blood and disease sites in tuberculosis patients. publication-title: Am J Respir Crit Care Med – volume: 176 start-page: 409 year: 2007 article-title: Regulatory t cells depress immune responses to protective antigens in active tuberculosis. publication-title: Am J Respir Crit Care Med – volume: 7 start-page: 428 year: 2007 article-title: T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. publication-title: Lancet Infect Dis – volume: 31 start-page: 261 year: 2008 article-title: Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot. publication-title: Eur Respir J – volume: 86 start-page: 303 year: 2006 article-title: Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis. publication-title: Tuberculosis (Edinb) – volume: 265 start-page: 163 year: 2009 article-title: Recruitment of Mycobacterium tuberculosis specific CD4+ T cells to the site of infection for diagnosis of active tuberculosis. publication-title: J Intern Med – volume: 2 start-page: e926 year: 2007 article-title: Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis. publication-title: PLoS ONE – volume: 157 start-page: 729 year: 1998 article-title: Local immune responses correlate with presentation and outcome in tuberculosis. publication-title: Am J Respir Crit Care Med – volume: 12 start-page: 1135 year: 2005 article-title: Patients with pulmonary tuberculosis develop a strong humoral response against methylated heparin-binding hemagglutinin. publication-title: Clin Diagn Lab Immunol – volume: 29 start-page: 337 year: 2007 article-title: Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins. publication-title: Eur Respir J – volume: 9 start-page: 818 year: 2002 article-title: Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. publication-title: Clin Diagn Lab Immunol – volume: 239 start-page: 33 year: 2004 article-title: Expression and purification of recombinant methylated HBHA in Mycobacterium smegmatis. publication-title: FEMS Microbiol Lett – volume: 10 start-page: 935 year: 2004 article-title: Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin. publication-title: Nat Med – volume: 3 start-page: e1536 year: 2008 article-title: Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. publication-title: PLoS ONE – volume: 11 start-page: 195 year: 2005 article-title: Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. publication-title: Curr Opin Pulm Med – volume: 187 start-page: 243 year: 2003 article-title: Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis. publication-title: J Infect Dis – volume: 19 start-page: 1601 year: 2005 article-title: Expression of a novel cytokine, IL-4delta2, in HIV and HIV–tuberculosis co-infection. publication-title: AIDS – volume: 149 start-page: 177 year: 2008 article-title: Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. publication-title: Ann Intern Med – volume: 40 start-page: 184 year: 2005 article-title: Ex vivo characterization of early secretory antigenic target 6-specific t cells at sites of active disease in pleural tuberculosis. publication-title: Clin Infect Dis – reference: 20805186 - Thorax. 2010 Sep;65(9):842; author reply 842-3 |
| SSID | ssj0008117 |
| Score | 2.2010577 |
| Snippet | Background:The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T... Background: The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T... The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and... |
| SourceID | proquest pubmed pascalfrancis crossref istex bmj |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 847 |
| SubjectTerms | Adult Antigens Antigens, Bacterial - metabolism Bacterial diseases Bacterial diseases of the respiratory system Bacteriological Techniques - methods Biological and medical sciences Biopsy Bronchoalveolar Lavage Fluid - immunology Cardiology. Vascular system Drug resistance Enzyme-Linked Immunosorbent Assay Female Histology HIV Human bacterial diseases Human immunodeficiency virus Humans Infections Infectious diseases Interferon-gamma - metabolism Lavage Lymphocytes Male Medical sciences Microscopy Mycobacterium tuberculosis - immunology Patients Pneumology T-Lymphocytes - immunology Tuberculosis Tuberculosis and atypical mycobacterial infections Tuberculosis, Pulmonary - diagnosis Tuberculosis, Pulmonary - immunology |
| Title | Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis |
| URI | https://thorax.bmj.com/content/64/10/847.full https://api.istex.fr/ark:/67375/NVC-3T0K0QJQ-R/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/19592392 https://www.proquest.com/docview/1781826871 https://www.proquest.com/docview/67672340 |
| Volume | 64 |
| WOSCitedRecordID | wos000270269700006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection (Proquest) customDbUrl: eissn: 1468-3296 dateEnd: 20250609 omitProxy: false ssIdentifier: ssj0008117 issn: 0040-6376 databaseCode: 7X7 dateStart: 19460301 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1468-3296 dateEnd: 20250609 omitProxy: false ssIdentifier: ssj0008117 issn: 0040-6376 databaseCode: BENPR dateStart: 19460301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwEB6xLUJceD8CS7EEQlyym8Sx45wQrHaFQFTbVUG9WY4folDSkgda_j3jJO1qDwsHLkkkx87js7-Z2JNvAF6iRXYC7VTovAIhsh8PC6N4KIpUxYbFNMtNl2wim07FYpGfDhNu9RBWueXEjqjNWvs58sM4E94VRv_-zeZn6LNG-dXVIYXGHoy9Ulk6gvG74-np2Y6L_W-U27g5jmNpEPeJKT9svp73cpVx7EvQthQ_vl2yTmP_os99tKSq8YW5PtPF1a5oZ5JObv_vw9yBW4MzSt72vecuXLPlPbjxaVhuvw_zWavK7i805ESyQl4gc-Kn-knVh9bamqilIehEkkpt8Mj0kXvLmqwd2bQrvJCqfpOmLWyl25UveQCfT47nR-_DIQ1DWCCLNiGzEXNGFUwXsSmoi5W1NNW5TRBNwVPNHdMJS7jmBcstfoFEwnHmLE2iLLeUPoRRuS7tYyDC5sZ4CRyr05SlDp1PgTthC8WVTlQALxAEuemFNmT3gUK5RKh8usxc9lAFcLAFSepBydwn1FhdXeH1rsI_237Vob47T1XffexbxuT0y5Gk8-hjNPswk2cBTC51i12FxMv1xEIEsL_FXg68UMsL4AN4vivGEe2xU6Vdt7X0EnoJTaMAHvW96-KeseUEHdonf2_6Kdzs1ry6kMN9GDVVa5_Bdf2rWdbVBPayRdZtxWQYLn8A7V0Y8Q |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5VLQIuvB-B0lriIS6heTrOASFUqFq2XbFoQXszjuOIhSW75AHtn-I3MpNX1UPh1AOnRPLaSnY-fzOOP88APEGPnAn0U3ZGGQiR_bidpIrbIgmUm4auH8VpU2wiGo_FbBa_X4Pf_VkYklX2nNgQdbrU9I18x40EhcIY379a_bCpahTtrvYlNFpYjMzJL1yylS8P3qB9n3re3tvp7r7dVRWwEySFyg6NE2apSkKduGniZ64yxg90bDx8OMEDzbNQe6HHNU_C2GBA7YiMh5nxPSeKDX0ARcrfQB6PSEIWzYYFnkOHNnuVHseZ26UScn2-U305bpNjui61oCdLvn894ws3yKzHpM1UJZona-tqnB_4Ng5w7_r_9tfdgGtdqM1et3PjJqyZ_BZcPurEBLdhOqlV3pyxQ8ZnC2Q9NmW0kcGKVjhsSqbmKcMQmRVqhXdpq0ucl2yZsVW9wBdTxQmr6sQUul5Qyx34eCHvdBfW82Vu7gMTJk5TSvBjdBCEQYahtcCLMIniSnvKgsdodLlq04jIZvnlc4nQoGKgsWyhYcGLHhRSd3naqVzI4vwOz4cO_xz7WYOy4Xeq-EbKviiU40-70p86I2fybiI_WLB1BoZDB4-SEblCWLDZY012rFfKU6BZsD00I1-R7VRulnUpKUGg5weOBfdaNJ8-M47sYbj-4O9Db8OV_enRoTw8GI8ewtVmd68RV27CelXU5hFc0j-reVlsNZOTweeLhvQfS8J0MA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxEB5VCaq48H4slNYSD3FZsi97vQeEoG1ECURJFVBvxuu11ZSQhN0stH-NX8d4H6l6KJx64LQreW3ZO59nxvbnGYBnaJENRzvlGhuBELUfc9NMMpenkfQz6odxklXJJuLhkB8dJaMN-N3ehbG0ylYnVoo6Wyi7R97zY25dYfTve6ahRYz2-m-WP1ybQcqetLbpNGqIDPTZL1y-Fa8P9lDWz4Ogvz_Zfe82GQbcFBXEyqXaoyaTKVWpn6Wh8aXWYaQSHWBHOYsUM1QFNGCKpTTR6Fx73DBqdBh4caLtZiiq_26MTgbtQPfd_nB0uLYD9gpny9ljOI-bwEJ-yHqr49M6VKbv2xK0a-n3kwuWsWuFfGqZmrJAYZk6y8blbnBlDvs3_-cfeQtuNE44eVvPmtuwoed3YPNTQzO4C5NxKefV7Tu0BWSG-pBMiD3iIHlNKdYFkdOMoPNMcrnEt6xmLE4LsjBkWc5wYDI_I6sy1bkqZ7bkHny-kjHdh858MdcPgXCdZJkN_aNVFNHIoNPN8cF1KplUgXTgKQJALOsAI6JamIVMIExsmtBE1DBx4FULEKGaCO42kcjs8gov1xX-2faLCnHr72T-zXL-YiqGX3ZFOPEG3vjDWBw6sH0BkusKgQ1T5HPuwFaLO9How0Kcg86BnXUxajIrOznXi7IQNnRgEEaeAw9qZJ_3GVsOcI49-nvTO7CJSBYfD4aDx3C9OvarWJdb0FnlpX4C19TP1bTIt5uZSuDrVWP6DzCiflA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantitative+lung+T+cell+responses+aid+the+rapid+diagnosis+of+pulmonary+tuberculosis&rft.jtitle=Thorax&rft.au=DHEDA%2C+K&rft.au=VAN+ZYL-SMIT%2C+R.+N&rft.au=SEMPLE%2C+P&rft.au=VLLHITELAW%2C+A&rft.date=2009-10-01&rft.pub=BMJ+Publishing+Group&rft.issn=0040-6376&rft.volume=64&rft.issue=10&rft.spage=847&rft.epage=853&rft_id=info:doi/10.1136%2Fthx.2009.116376&rft.externalDBID=n%2Fa&rft.externalDocID=21959188 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0040-6376&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0040-6376&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0040-6376&client=summon |